Anbio Biotechnology Class A Ordinary Shares (NNNN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.53M | 18.77M | 15.75M | 15.15M |
| Cash & Short-Term Investments | 11.76M | 10.31M | 9.69M | 10.56M |
| Cash Only | 11.76M | 10.31M | 9.69M | 10.56M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.06M | 4.62M | 1.88M | 3.58K |
| Days Sales Outstanding | 102.5 | 46.91 | 21.81 | 0.4 |
| Inventory | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 387.44K | 176.99K | 62.14K | 280.07K |
| Property, Plant & Equipment | 0 | 0 | 0 | 3.27K |
| Fixed Asset Turnover | - | - | - | 1010.12x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 387.44K | 176.99K | 62.14K | 276.8K |
| Total Assets | 18.92M | 18.94M | 15.81M | 15.43M |
| Asset Turnover | 0.13x | 0.36x | 0.25x | 0.21x |
| Asset Growth % | 19.67% | 22.79% | - | - |
| Total Current Liabilities | 1.73M | 527.75K | 993.06K | 1.34M |
| Accounts Payable | 1.63M | 478.96K | 827.15K | 1.31M |
| Days Payables Outstanding | 245.84 | 28.43 | 43.12 | 349.92 |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 |
| Current Ratio | 10.71x | 35.56x | 15.86x | 11.29x |
| Quick Ratio | 10.71x | 35.56x | 15.86x | 11.29x |
| Cash Conversion Cycle | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.73M | 527.75K | 993.06K | 1.34M |
| Total Debt | 0 | 0 | 0 | 0 |
| Net Debt | -11.76M | -10.31M | -9.69M | -10.56M |
| Debt / Equity | - | - | - | - |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | -2.65x | -16.50x | -6.83x |
| Interest Coverage | - | - | - | - |
| Total Equity | 17.19M | 18.42M | 14.82M | 14.09M |
| Equity Growth % | 16.01% | 30.74% | - | - |
| Book Value per Share | 0.41 | 0.44 | 0.35 | 0.33 |
| Total Shareholders' Equity | 17.19M | 18.42M | 14.82M | 14.09M |
| Common Stock | 14.23K | 14.23K | 14.23K | 14.23K |
| Retained Earnings | 17.17M | 18.4M | 14.8M | 14.07M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |